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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Germinated barley foodstuff contains prebiotics which are reported
to have anti cancerous effects in colorectal cancer model, but the
detailed mechanism remains unclear. Recent studies revealed that
the role of microbiota was strongly related to the regulation of
incidence and progression of colorectal cancer. The aim of this
study was to examine the anti neoplastic mechanism by prebiotics.
Azoxymethane treated F344 rats were used as the sporadic
cancerous model. After azoxymethane injection, either a control
or germinated barley foodstuff diet was administered to the rats
for another 5 weeks, and the number of abberant crypt foci, toll
like receptor 4, Kirsten rat sarcoma viral oncogene homolog,
adenomatous polyposis coli tumor suppressor gene and cyclo 
oxygenase 2 mRNA expression of colonic mucosa and cecal short
chain fatty acids were examined. The germinated barley food
stuff significantly attenuated the number of abberant crypt focis
and the expression of toll like receptor 4 and cyclooxygenase 2
mRNA, compared to the control group. In addition, the cecal
butyrate production in the germinated barley foodstuff group
was significantly higher than that in the control. In conclusion,
this prebiotic treatment for colorectal cancer may be useful with 
out causing the adverse effects seen in either anti cancer drugs or
anti inflammatory drugs.
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Introduction The colon is different from the other digestive organs, because
it harbors an enormous number of coexisting microbiota.(1)
Dietary fiber has been shown to prevent colorectal cancer (CRC)
by diluting or adsorbing fecal carcinorgens (i.e. endogenous bile
acid metabolite, food-derived carcinogen), thus reducing the
colonic transit time, alternating the bile acids metabolism,
increasing short chain fatty acids (SCFA) accompanying the
change in microbiota,(2) although this is also a controversial
issue.(3) Germinated barley foodstuff (GBF) is a heterogeneous
mixture of insoluble protein and dietary fiber that functions as a
prebiotic in the intestine, and is effective in patients with active
ulcerative colitis.(4) GBF has a potent effect and it increases the
number of microbiotic metabolites, including SCFA and butyrate,
which is an anti-inflammatory reagent and can also induce
apoptosis in cancer cells.(5,6) Because butyrate produced by micro-
biota following prebiotic treatment is stably maintained at a
physiological concentration in the entire colon, this prebiotic
treatment may therefore be a useful medical option for reducing
the risk of CRC.(7)
Aberrant crypt foci (ACF) are lesions consisting of a large and
thick crypt in methylene blue stained colonic mucosa, which
showed a loss of polarity, and the stratification of the nuclei in the
crypt epithelium histologically. ACF have been reported to be
precursors of adenoma and cancer, because patients with colon
cancer have a higher number of ACF than control subjects.(8)
Azoxymethane (AOM) is commonly used to mimic human
sporadic CRC in rodents, and pre-neoplastic lesions are detected
as ACF.(9,10) However, the detailed mechanism for the anti-
carcinogenic effects of GBF still remains poorly understood.
Recent studies have revealed that toll like receptor 4 (TLR4)
or one of the sodium-coupled monocarboxylate transporters
(SLC5A8 also known as SMCT-1) was strongly related to the
regulation of incidence and progression of CRC.(11,12) Both para-
meters were related to the microbiota (TLR4) or its metabolites
(SLC5A8), respectively. TLR4 has been identified as one of the
regulators of the mucosal immune system to lipopolysaccharide
(LPS), the pathogenic product of gram negative microbiota in the
colon, and TLR4 were recently reported to show an increased
expression in colon cancers, compared to the normal mucosa.(13)
Interestingly, the microbiota metabolite butyrate resulted in the
downregulated TLR4 expression and IL-8 production in HT29
cells,(14) and also stimulated the expression of SLC5A8, which
induced anti-carcinogenic effects in the colon.(12)
In the present study, we evaluated the anti-cancerous mecha-
nism of prebiotic GBF on the sporadic AOM-induced CRC model,
particularly in the modulation of the microbiota and the changes in
its metabolites, to examine the role of TLR4, a key regulator of the
mucosal barrier functions.
Materials and Methods
Chemical composition and physiological characteristics of
GBF. GBF consists of the aleurone and scutellum fractions of
germinated barley, and is made by milling and sieving the residue
of brewers’ spent grain. The dietary fiber fraction of GBF is
primarily composed of low-lignified hemicellulose, which accumu-
lates in the scutellum and aleurone fractions, as the roots and
shoots of barley are produced during germination. During
germination, GBF exhibits a conspicuously higher water-holding
capacity than other insoluble dietary fiber types.(15) As described in
our previous study, GBF contains approximately 46% protein and
30% dietary fiber by weight.(16)
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Animals and treatments. All animal experiments were
approved by the Kirin Holdings animal experiments ethical
committee and the Nihon University animal experiments ethical
committee. Rats were housed individually in cages in a room kept
at 20 to 25°C with 40 to 70% relative humidity on a 12-h lighting
cycle (conventional conditions). The animals had free access to
both food and drinking water.
Sporadic colon cancer model induced by AOM. Twenty
5-week-old male Fischer 344 rats were purchased from Charles
River Japan (Kanagawa, Japan). First, the 20 rats were fed
laboratory chow for 1 week during the acclimatization period. We
started the experiments, and the rats were divided into two groups
(n = 10/group). One group received a control diet, and the other
group received the GBF diet. The total volume of protein and
dietary fiber in both diets was adjusted to 14.6% protein and 3.0%
dietary fiber, respectively (Table 1). After two weeks of pre-
feeding using the respective experimental diets, the rats were
given two subcutaneous injections of AOM at a dose of 15 mg/kg
body weight once per week for two continuous weeks.(17) After the
second AOM injection, the rats were administered the respective
diets for more 5 weeks ad libitum, and were euthanized thereafter.
Changes in the body weight and food intake are shown in Fig. 1.
On the final day, rats were anesthetized with pentobarbital (i.p.),
and the serum, colon and cecal contents were collected.
Histological examination. The entire colon was obtained
for the histological observation of ACF. The rectum segment
approximately 5 cm from the pectinate line was fixed in 4%
buffered paraformaldehyde (Wako Pure Chemicals Ind., Osaka,
Japan) and stained with 0.2% methylene blue. In accordance
with the methods carried out in a previous report, the ACF were
scored under a light microscope (Carl Zeiss Axioskop 40 and
AxioVision, Japan) with an area of 1 cm2 of colon being quantified
at 100× magnification.(17) ACF were distinguished from normal
crypts by their increased size, more prominent epithelial cells,
and increased pericryptal area, and representative ACF images
are shown in Fig. 2.
Reverse transcription polymerase chain reaction (RT PCR)
to examine the mucosal expression of mRNA. Residual
colonic mucosal specimens were evaluated for the mucosal
expression of TLR4, Kirsten rat sarcoma viral oncogene homolog
(KRAS),(18) adenomatous polyposis coli tumor suppressor gene
(APC) and cyclooxygenase 2 (COX2) mRNA using reverse
transcription-polymerase chain reaction (RT-PCR).(19,20) according
to the methods used in our previous study.(21) Briefly, total mucosal
RNA was isolated using the Trizol reagent (Invitrogen Japan,
Tokyo). First-strand cDNA was synthesized using an oligo (dT)
primer and Superscript II reverse transcriptase (GIBCO BRL,
Rockville, MD) and PCR was performed thereafter (10 X Taq
Buffer and Taq Gold polymerase, thermal cycler; GeneAmp 2400;
Perkin Elmer Cetus Co., Norwalk, CT). The PCR products were
subjected to electrophoresis on 1.5% agarose gels and were
stained with ethidium bromide. Primers specific for TLR4, APC,
KRAS, COX2 and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; as housekeeping gene) were constructed according to
the open software program for designing PCR primers (http://
frodo.wi.mit.edu/primer3/): (Shown in Table 2).
Organic acids analysis of cecal content. An organic acid
analysis of the cecal contents in rats fed the respective diets was
performed. Briefly, 0.2 g of the cecal contents were weighed, then
1.0 ml of Milli-Q water was added and the mixture was incubated
at 4°C for 30 min. After centrifugation at 12,000 rpm at 4°C, for
10 min, the supernatant was obtained, and continuously filtered
using a 0.22 μm filter. The organic acids were separated with the
Shim-pack SPR-H 250L (Shimadzu Co. Ltd., Kyoto, Japan). The
mobile phase was 4 mM of p-toluene sulfonic acid, and the
detector was electric conductivity (Shimadzu CDD-6A, Kyoto,
Japan).(16)
Statistical analysis. All values are presented as the
mean ± SD. Comparisons of data were made using Student’s t test
or the χ2 test. Differences were considered to be statistically
significant for p values of less than 0.05.
Table 1. Composition of the experimental diets
*Germinated Barley Foodstuff (GBF) (Protein; 46.3%, Dietary fiber;
34.0%).
** According to AIN 93G formula.
Control GBF*
(g/kg diet)
Casein 146 100
Vitamin Mix** 10 10
Mineral Mix** 35 35
Choline chloride 2 2
Cellulose 30 0
GBF 0 100
Corn oil 50 50
Corn starch 727 703
Fig. 1. Changes in body weight and food intake in rats fed either
the control (Cont) or the germinated barley foodstuff (GBF) diet. The
arrows show the time of the injection of azoxymethane (AOM) sub 
cutaneously. Data are expressed as the mean changes ± SD. *Represents
significant differences between the Cont and GBF groups (p<0.05).
Fig. 2. The number of aberrant crypt foci (ACF) were counted under a
light microscope (Carl Zeiss Axioskop40 and AxioVision, Japan) per
1c m 2 of the distal colon at 100× magnification. The data are expressed
as the mean changes ± SD. ACF in the germinated barley foodstuff
(GBF) group were significantly lower than in the control (Cont) group.
*p<0.05 for the differences between the Cont and the GBF. Representa 
tive ACF in the colon are shown (100×). Aberrant crypts appeared larger
and had a thicker epithelial lining compared to normal crypts, and were
gathered into a focus consisting of several crypts. *Represents signifi 
cant different between Cont and GBF groups (p<0.05). J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 59
©2011 JCBN
M. Fukuda et al.
Results
Fig. 1 shows the changes in the body weight, food intake and
the schedule of AOM administrations. The control group had
significant lower body weights than the GBF group, although
there were no significant differences in the food intake between
the groups. The detailed reason for this observation is still
unknown; GBF may have the ability to attenuate the damage
induced by carcinogenic AOM. The number of ACF in 1 cm2
section of the colon is shown in Fig. 2. After GBF treatment, the
number of ACF was significantly lower than in the control group.
The data clearly showed that GBF prevented the onset of neo-
plastic changes in the early stages of carcinogenic sequence.(22)
In addition, the macroscopic observations revealed that adeno-
matous polyposis, inflammatory signs, including ulcer and ero-
sion, and squamous metaplasia were not observed in both groups.
Table 3 indicates the changes in the cecal organic acid content
of both groups. The GBF treatment group had a significant
increase in the production of butyrate compared to the control
group. Although our previous study demonstrated that GBF
significantly decreased succinate production, this trend did not
reach statistical significance between the groups (p = 0.057).
These data suggested that the composition of microbiota, espe-
cially anaerobic microbiota, were reorganized by prebiotic treat-
ment, accompanied by the changes in metabolite SCFAs. Fig. 3
shows the changes in the colonic mucosal mRNA expression of
TLR4, APC, KRAS and COX2. Following GBF treatment, the
mucosal TLR4 and COX2 mRNA was significantly decreased
compared to the control group. TLR4 was reported to play a
pivotal role in the development of colitis-associated neoplasia,
and the inhibition of TLR4 signaling may prevent dysplasia.(13)
In addition, the increase of COX2 mRNA in colorectal adeno-
carcinomas was observed, compared with normal colonic mucosa
in the same patients.(23)
The expression of KRAS mRNA was not significantly different
between the groups. The APC gene is considered to be a gate-
keeper gene which maintains the stability of the colonic epithe-
lium. It was also reported that carcinogenic treatment in rats
resulted in decreased APC expression.(22) APC mutations were
present at a relatively low level, and APC mutations did not
contribute to the initiation of ACF.(24) Although not statistically
significant, the expression of APC mRNA in the GBF group
tended to be higher than in the control group.
Discussion
It has previously been reported that sporadic colorectal carci-
noma has an adenoma-carcinoma sequence, in which genomic
instability and the loss of key tumor suppressor genes such as APC
result in the loss of p53 gene function, thereby driving the
adenoma to a carcinoma.(25) ACF have been detected in the colonic
mucosa in a rodent model as well as in human colon cancers, and
ACF, particularly large and dysplastic appearance foci, were
reported to be useful and identifiable precursors of adenoma and
carcinoma.(8) The number of ACF was significantly inhibited in
the GBF group compared to the control group. Prebiotic GBF had
anti-cancer effects in the present rodent model. In addition,
patients with colon cancer were found to have a greater number
of ACF than patients with noncancerous lesions, which was
accompanied by a high rate of KRAS mutations.(8,26) However,
we found that the change in KRAS expression, instead of KRAS
mutations, was less important in the present study, and we were
unable to detect any differences in KRAS expression between the
two groups.
The APC gene is considered to be one of the key component of
the β-catenin signaling pathway, which plays an important role
Table 2. Primer sequences used to analyze the host response by RT PCR
Primer was constructed according to the open software program for
designing PCR primers (http://frodo.wi.mit.edu/primer3/).
Target Direction Sequence
TLR4 Fw AGCCATTGCTGCCAACATCATCCAG
Rv TGCTGCCTCAGCAAGGACTTCTCCA
APC Fw TGCGGAATTTGTCTTGGCGAGCAG
Rv AAATGCCAGTGCCCCGTCCACA
KRAS Fw GGAGCTGGTGGCGTAGGCAAGA
Rv CAAAGAAAGCCCTCCCCAGTTCTCA
COX2 Fw ATCCCGCCCTGCTGGTGGAAAA
Rv GGCTGCGGGTCTTGCACATTGAA
GAPDH 
(as housekeeping gene)
Fw TGGCATGGCCTTCCGTGTTCCT
Rv TGCCAGCCCCAGCATCAAAGGT
Table 3. Cecal organic acid contents
* GBF means germinated barley foodstuff.
** represents significant difference between groups (p<0.05).
Control GBF*
(mM/g content)
Succinic acid 5.23 + 1.27 2.23 + 0.73
Acetic acid 45.05 + 2.92 43.41 + 2.45
Propionic acid 9.32 + 0.49 8.47 + 0.48
iso Butyric acid 3.32 + 0.17 2.99 + 0.10
Butyric acid 7.77 + 1.04 15.86 + 1.14**
Fig. 3. The expression levels of toll like receptor 4 (TLR4), cyclo 
oxygenase 2 (COX2), Kirsten rat sarcoma viral oncogene homolog
(KRAS) and adenomatous polyposis coli tumor suppressor (APC) genes
in the colonic mucosa were normalized to the expression levels of the
house keeping gene glyceraldehyde 3 phosphate dehydrogenase. The
levels of TLR4 and COX2 mRNA in the germinated barley foodstuff
(GBF) group were significantly lower than in the control (Cont) group.
The data are expressed as the mean changes ± SD. *p<0.05 for differ 
ences between the Cont and the GBF groups.doi: 10.3164/jcbn.10 114
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in colon carcinogenesis. APC mutations are reported to be respon-
sible for the accumulation of β-catenin in the nucleus, and the
constitutive activating transcription of T-cell factor or lymphoid
enhancer factor. Therefore, APC mutations activated the oncogene
β-catenin signaling pathway.(27,28) However, APC mutations have
been reported to be present at relatively low levels, and the APC
mutations did not contribute to the development of ACF.(24) GBF
may therefore reinforce the role of the gatekeeper genes in the
present experiment, because carcinogen-treated rats have been
reported to cause a decrease in the APC mRNA expression.(22) In
the present study, the expression of APC gene was slightly higher
in the GBF group than in the control group, although this trend did
not reach statistical significance (p = 0.20). In the future, we will
evaluate the detailed mutation profiles of the APC and KRAS
genes in this colon cancer model to confirm the anti-carcinogenic
mechanism of GBF treatment.
Interestingly, the level of COX2 mRNA of colonic mucosa in
patients with colorectal cancer has been reported to be markedly
elevated, compared with that of healthy controls(23,29) and thus
reducing the COX2 expression by green tea may contribute to
the attenuation of colonic neoplastic lesions in rats.(10) In our
experiment, the colonic mucosal mRNA expression of COX2 was
significantly lower in the prebiotic GBF group than in the control.
The present study suggested the modulation of microbiota by
the prebiotic GBF, which was comprised of an increase in butyrate
in the lower intestinal tract. Butyrate has been reported to have
anti-neoplastic effects under physiological concentrations (2–5
mM) due to cell cycle regulation (increased apoptosis in colonic
tumor cell lines).(30) Interestingly, butyrate, a metabolite of micro-
biota induced by anaerobic fermentation in the lower intestine, has
been shown to suppress TLR4 gene expression.(31) The ligand of
TLR4 is well-known to be LPS, and LPS induces the degradation
of IκBα, which results in the transmigration of nuclear factor
kappa B (NF-κB) to the nucleus, where it binds to DNA and
induces the production of pro-inflammatory cytokines.(31) Although
the detailed mechanism remains unclear, LPS stimulated the
induction of IL-8 in the HT-29 cell line, and butyrate has been
reported to attenuate LPS-induced IL-8 production, and this anti-
inflammatory action is considered to cause a downregulation of
the TLR4 expression.(14) In addition, TLR4 was upregulated in
ulcerative colitis patients, and TLR4 was reported to detect the
gram negative microbiota and to activate the innate immune
system.(32) Furthermore, a recent study revealed that TLR4 had the
ability to regulate the COX2 expression in chronic colon cancer
model via NF-κB expression.(32,33) In the present study, GBF
decreased the TLR4 expression through an increase in butyrate
production and decrease of COX2 expression, compared with that
of the control group. In our previous study, butyrate and short
chain fatty acids also dramatically attenuated the proinflammatory
cytokine IL-6 production as well as the TLR4 mRNA expression
in the T84 cell line.(34)
Increased butyrate in the present study may therefore have
contributed to the increased tumor suppressor action, as described
by other reviews.(35) Coleman et al.(36) reported the inverse correla-
tion between butyrate concentration and the number of ACF to
suggest a pivotal mechanism of protection against neoplasia.
These actions have been reported and include the upregulation
of carcinoembryonic antigen-related cell adhesion molecule 1
(CEACAM1; increase of anoikis), the death receptor DR5
(increase of sensitivity to TNF-related apoptosis-inducing ligand)
and Fas-mediated cytotoxicity, and the downregulation of COX2
and glutathione (increased resistance to oxidative stress). Anti-
inflammatory agents, including NSAIDs, are also known to have
anti-tumorigenic effects due to the inhibition of NFκB activa-
tion.(37) In particular, butyrate has been reported to have anti-
inflammatory effects and it has thus been used for the treatment
of patients with chronic inflammatory bowel disease, including
ulcerative colitis, as an enema solution.(38) GBF has also been
reported to have an attenuated NFκB activity in a colitis model,(16)
and such anti-inflammatory effects may therefore play a pivotal
role in the progression of colon cancer. Prebiotics, and GBF in
particular, may deliver the natural anti-inflammatory agent
butyrate to the entire colon at physiological concentrations
without any adverse effects. These may play an important role in
the inhibition of CRC to control mild or undetectable inflam-
mation, as well as to monitor the invasion of pathogenic micro-
biota by TLR signals in the colon.
Considering the above factors, the appropriate improvement of
the microbiota in the AOM-induced sporadic colon cancer model
by prebiotics may contribute to the attenuation of low-grade
inflammation, and the reduced incidence of CRC. In conclusion,
GBF demonstrated a preventive effect on tumorigenicity in the
AOM-induced CRC model. Although more detailed GBF studies
concerning the mechanism of the onset of CRC, particularly
regarding the changes in the microbiota and its metabolites on
mucosal barrier function, are still required, the nutraceutical pre-
ventative treatments of GBF for CRC may be useful without
causing any of the adverse effects seen in treatments with either
anti-cancer drugs or anti-inflammatory drugs.
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